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1. Introduction 
Nutrition plays an important role in achieving optimal growth and development of the high 
risk neonate. Recent developments have shown that aggressive parenteral nutrition defined 
as relatively high amounts of parenteral protein and lipid commencing on the first day of 
life reduces the incidence of ex-utero growth retardation (EUGR) and associated morbidities.  
For preterm infants, early minimal enteral feed and a standardised feeding regime have 
improved clinical outcomes. Probiotics appear useful in further reducing the incidence of 
necrotizing enterocolitis (NEC).   
Short-gut syndrome is not infrequent after NEC and fish oil lipid emulsions are useful in the 
prevention and treatment of intestinal failure-associated liver disease (IFALD).  
Use of preformed silos has been shown to improve the outcomes of gastroschisis by 
decreasing the risk of abdominal compartment syndrome and iatrogenic gut ischemia.  
Until recently, neonatal haemochromatosis was considered uniformly fatal disease and only 
curative treatment was liver transplantation. Exchange transfusion and intravenous 
immunoglobulin therapy are emerging as potentially curative strategies for this condition.  
High index of suspicion and early diagnosis and management of malrotation is highly 
essential to prevent the dreaded complication of volvulus with intestinal gangrene.  
The WHO 2006 growth charts are useful in monitoring the subsequent growth term infants 
and avoid over-diagnosis of growth failure and under-diagnosis of obesity. These growth 
charts also have the potential of being useful in monitoring the growth of preterm infants 
after post-conceptional age of 40 weeks. 
In this chapter, we have reviewed all these recent advances and potentially better practices 
which most likely will help improve the outcomes of high risk neonates. 
2. Recent developments in nutrition for preterm infants 
Growth retardation after preterm birth or EUGR is defined as discharge weight less than the 
10th percentile of intra-uterine growth expectation. The risk of EUGR increases with 
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decreasing gestational age and birth weight. Dusick et al (Dusick et al. 2003) using NICHD 
network (National Institute of Child and Human Development) reported that nearly 100% 
of very low birth weight (501 – 1500g) infants have growth failure at 36 weeks post-
conceptional age (PCA). They also reported that 40% were still less than the 10th percentile 
for weight at 18 months of age.  
Impaired growth during and after discharge from hospital is associated with increased 
neurodevelopmental problem in infancy and early childhood(Latal-Hajnal et al. 2003, 
Ehrenkranz et al. 2006). Current consensus is that the neonatologists should be focused on 
improving the early nutrient management of these infants, allowing them to reach an adequate 
growth rate (at least 18-20 g/kg/d), thereby avoiding the need of a late un-physiological catch-
up growth(Fanaro 2010). Hence, nutritional guidelines have been revised with the aim of 
reducing EUGR and sequalae (Tsang R et al. 2005). The revised nutritional recommendations 
theoretically should result in body composition similar to a healthy fetus that has less body fat 
than most preterm infants currently have at term. The new guidelines recommend protein 
intakes of 3.5 to 4.5g/kg/day and up to 130 – 150 kcal/kg/day.  
Once EUGR occurs, excessive catch up growth may lead to increased adiposity and insulin 
resistance and metabolic syndrome later in life (Yeung 2006, Morrison et al. 2010). This has 
led to a dilemma after discharge: whether to aim for better nutrition to achieve improved 
neurodevelopmental outcomes, which may come at a cost of early-onset obesity and 
diabetes (Ong 2007). 
A recent randomised trial has shown that catch-up growth if achieved with optimal 
nutrition may not lead to excessive central adiposity(Cooke et al. 2010). Preterm infants with 
a GA <34 wk and a birth weight of <1750 g were randomized immediately before hospital 
discharge to be fed with a nutrient-enriched formula or a standard formula for 6 months. 
They found that more rapid and more complete “catch-up,” was noted in infants fed with 
the nutrient-enriched formula. This "catch-up" was due to increased fat free mass and fat 
accretion on the legs rather than central adiposity measured by DEXA. 
The results of this RCT provide some reassurance that catch up growth and hence improved 
neurodevelopmental outcomes may be achievable without paying the price of increased risk 
of obesity, diabetes and hypertension. Similar studies and long term follow up are desirable 
to gain further knowledge in this area. 
2.1 Parenteral nutrition 
In extremely preterm infants, at least 1.5g/kg/day of protein is required to prevent negative 
nitrogen balance and 3.5g/kg/day to achieve positive balance (fetal equivalent) . It has been 
calculated that if a 26 week gestation infant receives only glucose, he will have a 25% deficit 
of body protein by 1 week of age (Dusick et al. 2003). There is evidence from randomised 
controlled trials that an aggressive nutritional regime in the early weeks can minimise the 
large protein deficit most ELBW babies incur, and reduce the rate of extra-uterine growth 
retardation (Wilson et al. 1997, Dinerstein et al. 2006). Starting parenteral nutrition on day 1 
and providing at least 3g/kg/day amino acids by day 5 will reduce the incidence of EUGR, 
improve nitrogen retention and maintain amino acids within the fetal reference 
range(Poindexter et al. 2006, te Braake et al. 2007). Extremely low birth weight (ELBW) 
infants require 70 kcal/kg/d for basal metabolic rate. Their glucose requirement is 8-12 
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mg/kg/min (45-56 cal) with the balance of non-protein cal given as intravenous lipid. Early 
lipid (day 2-4), up to 3g/kg/d (27cal/kg/d) is well tolerated with no documented adverse 
effects(Simmer and Rao 2005). The lipid emulsion currently used in Australia is based on 
soybean oil and is rich in essential fatty acids (EFA, 60%). Alternative lipid emulsions with a 
mixture of olive, and soybean oil are available commercially in some countries. Advantages 
of the new blends include lower EFA content and more alpha tocopherol which may result 
in improved ability to synthesise longer chain metabolites which are the precursors of 
eicosanoids, reduced lipid peroxidation and oxidative stress, and attenuation of 
immunosuppressive effects linked to LA. More recently, fish-oil based emulsions have been 
introduced to prevent and treat parenteral-nutrition induced cholestasis, and to provide 
preformed DHA. Lipid emulsions available for neonatal parenteral nutrition are reviewed 
by Deshpande & Simmer (2011) (Deshpande and Simmer 2011). 
2.2 Enteral nutrition 
Minimal enteral feeds, even for very immature infants, should be started in the first few 
days at 5 – 10mls/kg/day of human milk. The earlier that enteral feeds are commenced, the 
earlier full enteral feeds are achieved. Early full enteral feeds is associated with reduced late 
onset sepsis with no increase in NEC (Ronnestad et al. 2005, Kennedy et al. 2000). Mother’s 
own milk (MOM) is the feed of choice as benefits include improved intelligence, lower 
infection rates and less NEC (Vohr et al. 2006, Schanler 2001).  
Early milk has higher content of nutritional and immunological factors and should be used 
first. Freezing the milk will greatly reduce the viral CMV load and therefore risk of CMV 
transmission from unpasteurised milk. If inadequate MOM available, pasteurised donor 
human milk (PDHM) is preferred to artificial formula. All human milk will require 
fortification for preterm infants to meet recommended nutritional intakes for optimal 
growth. Feeds are usually fortified after full enteral feeds are tolerated because of possibility 
that the higher osmolality of fortified milk may contribute to NEC. Commercial fortifiers 
contain protein, energy, calcium, phosphate, sodium, minerals and vitamins and are well 
tolerated by most preterm infants. If MOM and PDHM are unavailable, preterm infants 
should be fed preterm formula rather than term formula until discharge, as it is tailored to 
meet the nutritional needs of preterm infants. There is concern that cows’ milk protein is a 
risk factor for NEC and for allergic disease in childhood (Berg et al. 2010, von Berg et al. 
2008) and there are commercial fortifiers and preterm formula available that do not contain 
intact cows’ milk protein. 
2.3 Human Milk Banks (HMBs) 
For preterm infants PDHM reduces the incidence of NEC four fold and improves feed 
tolerance(Quigley et al. 2007). This may be associated with reduced days of parental 
nutrition and earlier discharge from hospital. Pasteurisation reduces the protective effects of 
human milk but feeding PDHM is still associated with a lower incidence of infections than 
feeding formula. 
Most informal HMBs closed in the 1980’s due to the discovery that the HIV virus could be 
transmitted through breastfeeding. Many countries have now re-established human milk 
banking with comprehensive risk management processes, most HMBs provide PDHM for 
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preterm infants while in hospital. In Australia, the HMB runs by the code of good 
manufacturing practices (blood and tissues) and models risk management on codex HACCP 
(Hazard Analysis Critical Control Point) requirements(Hartmann et al. 2007). Parental consent 
for PDHM is obtained by lactation consultants to ensure full support of breastfeeding.  
2.4 High dose supplements 
Long chain polyunsaturated fatty acids (LCPUFA) especially docosahexaenoic acid (DHA) 
may be important for optimal neurological development of preterm infants. The Cochrane 
Review of LCPUFA supplementation of formula for preterm infants found that there was 
little evidence to support a benefit but a suggestion but supplementation was usually low 
dose as it was aimed at breast milk equivalence (0.2-0.5% DHA) (Schulzke et al. 2011). 
Makrides et al (2009) randomised 657 infants < 33 weeks gestation to high dose DHA, 
(approximately 1% DHA aimed at in utero supply) by supplementing lactating mothers to 
increase breast milk DHA (average breast milk levels). Bayley mental developmental index 
was higher at 18 months (girls only) and there was less developmental delay (all infants) 
especially in the < 1250 g subgroup, with high dose DHA supplementation compared with 
low-moderate dose (0.3% DHA). (Makrides et al. 2009).  
Vitamin A is required for normal lung growth and meta-analysis of clinical trials suggests 
that Vitamin A supplementation is associated with reduction in death and chronic lung 
disease in preterm infants. The optimal dose for extremely low birth weight infants (<1kg) 
appears to be 5000 IU IM three times weekly for four weeks (Darlow and Graham 2007). 
Vitamin A delivery from parenteral nutrition is better if added to lipid emulsion. 
Probiotic supplementation of VLBW infants reduces death and NEC (Deshpande et al. 2010). 
Sourcing a preparation is challenging in most countries. On-line evidence-based guidelines 
for the use of probiotics in preterm infants are available(Deshpande et al. 2011). 
In summary, avoidance of postnatal growth retardation, early parenteral nutrition with 
fish/olive oil based lipid emulsions, early enteral feeding with human milk, supplementation 
with DHA, vitamin A and probiotics are potentially best practices to achieve optimal clinical 
outcomes after preterm birth. 
3. Intrauterine growth restriction 
3.1 Definition and diagnosis 
Birth weight is determined by gestational age at time of delivery and by fetal growth rate (5 
g/d at 14-15 wk gestation; 10 g/d at 20 w gestation; 30-35 g/d at 32-34 w gestation) 
(Williams et al. 1982)) and its classification describes an infant’s birth weight relative to a 
population reference. In statistical terms, small for gestational age (SGA) denotes a birth 
weight two standard deviations (SD) below the median birth weight for gestational age 
(GA). Although <2 SD below the median approximates the 2.3rd percentile(De Curtis and 
Rigo 2004), and may be a more relevant cutoff for indicating perinatal risk, neonates with a 
birth weight below the 10th percentile for GA are commonly classified as SGA. The term 
SGA is often used synonymously with intrauterine growth restriction (IUGR), largely 
because of the difficulties associated with diagnosing IUGR. However, the SGA infant 
population is a heterogeneous group, with some being constitutionally small, without any 
 
Recent Advances in Neonatal Gastroenterology and Neonatal Nutrition 
 
43 
underlying pathology (80-85%) whilst others have demonstrated IUGR, implying 
conceptually, that genetically determined growth potential has not been achieved in 
utero(Breeze and Lees 2007, Levene et al. 2000). Distinction between a healthy small fetus 
and one with IUGR can be facilitated by ultrasound examination to detect chromosomal 
abnormality, amniotic fluid volume changes, serial fetal growth symmetry monitoring and 
Doppler studies. Utilising customised standards for fetal growth and birth weight that 
adjust for maternal variables of height, weight, parity and ethnic group, may further 
improve the accurate detection of IUGR(Figueras and Gardosi 2011). The aim of identifying 
IUGR is to reduce associated perinatal morbidity and mortality, primarily by optimising the 
timing and mode of delivery of the growth restricted fetus.  
3.2 Incidence and aetiology 
The study of IUGR has been thwarted by ambiguous terminology and a lack of uniform 
standards and diagnostic criteria. Most recently this ambiguity has been demonstrated by 
Olsen et al.(2010). These investigators compared new intrauterine growth curves based on 
US data collected from 391 681 racially diverse infants to the commonly used Lubchenco 
curves(Lubchenco et al. 1963) and found that the SGA classifications differed significantly 
for each gestational age (p<0.0001), with the Lubchenco curves underestimating the 
percentage of infants who were SGA. Similarly, Goldenberg et al(1989) compared 13 
different standards from different populations and geographic areas and found a 
discrepancy of more than 500 g between GA-specific cut-off values used by different 
investigators to define IUGR. These anomalies affect the accuracy of incidence data. 
Nevertheless, IUGR is thought to affect 7-15% of all pregnancies worldwide(Alisi et al. 
2011), and a substantial proportion of IUGR fetuses are delivered preterm. IUGR is not a 
specific disease entity, but rather, is related to medical conditions compromising (i) 
placental circulation and efficiency (e.g. placental praevia, placental insufficiency and 
toxaemia of pregnanacy), (ii) fetal growth and development (e.g. chromosomal disorders, 
congenital malformations, multiple gestations and infection) and/or (iii) maternal health 
and nutrition (e.g. pregnancy induced hypertension, maternal hypoxia, vascular and renal 
disease, substance abuse and malnutrition)(Resnik 2002). The timing of the insult 
determines whether IUGR is symmetrical or asymmetrical, an outcome linked 
predominantly to the three phases of fetal growth (cellular hyperplasia: first 16 weeks of 
gestation; concomitant hyperplasia and hypertrophy: 16-32 weeks gestation; and cellular 
hypertrophy: 32 weeks to term). Early onset IUGR, arising from severe maternal vascular 
disease, infection (notably TORCH infections: toxoplasmosis, rubella, cytomegalovirus, 
varicella, HIV) and chromosomal or structural abnormalities such as cardiac and renal 
conditions, give rise to small infants with hypoplasia, who display symmetrical growth 
reductions in weight, length and head circumference (no head-sparing effect) and have a 
normal ponderal index (PI) [PI = (birth weight (g)/Length (cm)3)*100; normal PI is ≥ 2.41; 
low PI is <2.41]. These infants are unable to achieve their genetically determined growth 
potential. Later onset of IUGR results from utero-placental disorders and maternal factors 
leading to impaired delivery of oxygen and nutrients from the placenta. These factors come 
into play at different times and to varying degrees of severity during pregnancy, but 
generally, later onset IUGR results in asymmetric growth characterized by a relatively 
greater decrease in abdominal size (subcutaneous fat and liver volume), low PI, and sparing 
of head and length(Levene et al. 2000) with potential for some catch up growth. 
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3.3 Pathophysiology 
Compared to gestational-age matched peers, those with IUGR are at higher risk of 
morbidity and mortality(Damodaram et al. 2011), particularly if growth restriction is 
severe(Vossbeck et al. 2001, Wienerroither et al. 2001) and delivery is very preterm(Bernstein 
et al. 2000). The fetus chronically deprived of oxygen and substrates is at increased risk of 
stillbirth, fetal distress, congenital malformation, meconium aspiration, cord compression, 
premature rupture of membranes and preterm birth. Neonatal death, asphyxia, 
hypoglycaemia, meconium aspiration syndrome, polycythaemia, hyperviscosity, 
hypothermia, infection, pulmonary haemorrhage and transient neonatal hpyperglycaemia 
are anticipated features of the growth-restricted neonate(Damodaram et al. 2011, Levene et 
al. 2000). The IUGR preterm infant is also at increased risk of developing necrotizing 
enterocolitis and respiratory distress syndrome(Bernstein et al. 2000), and may demonstrate 
continued impaired growth and developmental delay(Bhide 2011, Levene et al.. 2000). IUGR 
is also associated in later life with features of the metabolic syndrome, including insulin 
resistance, hypertension, impaired glucose tolerance(Barker 2004) and very recently, 
nonalcoholic fatty liver disease(Alisi et al. 2011). The fetal adaptations to inadequate 
nutrition and subsequent IUGR that produce these long-term outcomes are incompletely 
understood but relate to fetal glucose and fuel metabolism. The adaptations have apparent 
survival value for the fetus by encouraging efficient glucose and energy utilization, by 
reducing uptake of amino acids for growth, by reducing production of anabolic hormone, 
and by increasing glucose supply to vital organs. In the short-term, these survival-motivated 
adaptations result in asymmetrical growth with some head and length sparing but if these 
adaptive mechanisms are prolonged or if their onset is more easily inducible in later life, the 
potential may exist for energy uptake beyond metabolic capacity(Thorn et al. 2011). The 
adverse outcomes of mismatched pre- and postnatal nutrition and catch up growth have 
been well demonstrated in animal models (Cleal et al. 2007, Ozanne and Hales 2004).  
3.4 Management 
The current treatment for IUGR is delivery and the main considerations need to be timing 
and mode of delivery, balancing the risk of neonatal morbidity with continued exposure to a 
stressful intrauterine environment. Careful monitoring of fetal and uteroplacental function 
with tests such as serial ultrasound scans, Doppler assessment of umbilical flow and cardiac 
monitoring will assist in determining optimal delivery time. Admission to a special care 
nursery (SCN) for observation is necessary for the severely growth restricted infant. It is 
worth noting that the IUGR phenotype includes decreased pancreatic development and 
insulin secretion capacity, as well as an up-regulated capacity for glucose uptake and a 
decreased capacity for synthesising protein for growth(Hay 2008). As Hay(2008) suggests, 
this could mean that equal rates of amino acids infused into a chronically IUGR infant may 
not translate to the same increase in growth as that observed in the healthy fetus born 
preterm and further, that attempts to infuse higher rates of intravenous glucose may 
produce both lactic acidosis and lipogenesis more readily in the IUGR infant than in the 
healthy preterm infant. Nutrition recommendations that specifically target IUGR preterm 
infants are lacking. Feeding regimes for IUGR preterm infants are usually similar to those 
who are appropriately grown, with some caution as feeds are progressed because of 
increased risk of NEC. Attention should be given to providing adequate nourishment for the 
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IUGR preterm infant from birth so that percentiles are at least maintained and so that 
extrauterine growth is of proportionate composition to that of the age-matched fetus. 
3.5 Future research directions 
Future research should focus on developing nutrition recommendations and feeding 
strategies specific for IUGR preterm infants. 
Further investigation of the quality of catch up growth achieved by asymmetrically grown 
IUGR preterm infants in response to macronutrient and energy intakes and implications of 
catch up growth. 
Further elucidation of the mechanisms underlying fetal and postnatal adaptation to IUGR 
and the impact of these adaptations on long-term health. 
Standardisation of IUGR definition, diagnostic tools and method of diagnosis. 
4. Growth monitoring of preterm infants during NICU stay and post discharge 
Growth monitoring of preterm neonates is particularly important in the context of evidence 
that postnatal growth restriction is associated with long term adverse neuro-developmental 
outcomes (Ehrenkranz et al. 2006, Shah et al. 2006, Casey et al. 2006, Latal-Hajnal et al. 2003). 
Careful growth monitoring while in, and after discharge from, NICU has the potential to 
improve long term outcomes.  
4.1 Types of growth curves currently available for use in preterm infants 
A ‘standard’ chart represents the ideal healthy growth of a population and hence is of 
prescriptive nature. A ‘reference’ chart describes the population without making claims 
about the health of its sample and hence is descriptive in nature. At present, there are no 
standard growth charts for preterm infants. 
4.2 Intra uterine growth curves 
The American Academy of Pediatrics('American Academy of Pediatrics Committee on 
Nutrition: Nutritional needs of low-birth-weight infants' 1985) and Canadian Pediatric 
society('Nutrient needs and feeding of premature infants. Nutrition Committee, Canadian 
Paediatric Society' 1995) recommend intra uterine growth rates as the ideal growth of 
preterm infants. There are more than 25 studies reporting on such ‘intrauterine growth 
charts’. These have been best summarized by Karna et al (Karna et al. 2005). Lubchenko 
1963(Lubchenco et al. 1963) and Babson/Benda1976 (Babson and Benda 1976) charts are 
commonly used in many neonatal units around the world. Fenton et al(Fenton 2003) 
updated the Babson and Benda growth curves to develop contemporary ‘intrauterine 
growth curves’. Using preset criteria, three recent large population based surveys of birth 
weight for gestational age were identified. The Canadian study by Kramer(Kramer et al. 
2001) which had a sample size of 676,605 infants delivered between 22 to 43 weeks was used 
for updating the intrauterine weight section. Two large studies, one from Sweden(Niklasson 
et al. 1991) and one from Australia(Beeby et al. 1996) were used to update the intrauterine 
head circumference and length section. The data were averaged together using a weighted 
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average based on total sample size to derive the 3rd, 10th, 50th, 95th and 97th percentiles and 
create one growth chart. CDC 2000 growth charts were used to generate the growth curves 
from corrected gestation of 40 weeks onwards.  
The Fenton chart appears to be useful in monitoring the growth of preterm infants during 
their NICU stay till they reach corrected gestation of 40 weeks. It is used by many North 
American, European and Australian centres. Recently Olsen et al have published new 
intrauterine growth curves based on United States data(Olsen et al. 2010).  
The inherent problem with intrauterine growth charts is that, even though they are called 
“intrauterine” charts, they are in fact cross sectional data derived from anthropometry 
measured at birth on preterm infants delivered at various gestations. It is well known that 
fetuses delivered prematurely may not have reached full growth potential due various 
maternal/fetal morbidities and hence do not reflect the “ideal” growth. Also, these charts do 
not take into consideration, the normal 5-8% weight loss that occurs in healthy preterm 
infants in the first week of life. 
4.3 ‘Fetal growth curves’ 
Strictly speaking, only charts derived from longitudinal studies should be called growth 
charts, growth being a process extended over time(Bertino et al. 2007). Hence it may appear 
logical that ideal ‘intrauterine growth charts’ should be derived from serial and longitudinal 
assessment of physical parameters of weight, length and head circumference using fetal 
ultrasound technique(Johnsen et al. 2006). However, the drawback of this method is that 
fetal ultrasound is not very accurate in predicting the fetal weight. A systematic 
review(Chauhan et al. 2005) which analysed data from 58 articles over 28 years found wide 
variability in diagnostic accuracy of ultrasound examination in predicting the fetal weight. 
Another systematic review(Dudley 2005) concluded that the accuracy of estimated fetal 
weight using fetal ultrasound is compromised by large intra- and inter-observer variability. 
Also, maternal morbidities can result in fetal growth restriction, which in turn can result in 
non- ideal growth charts. In view of such limitations, fetal weight curves derived from the 
currently available ultrasound technology may not be appropriate for use as ideal postnatal 
growth of preterm infants.  
4.4 Reference’ Growth charts 
Many reference charts that describe the actual longitudinal growth of preterm infants 
during the course of their stay in the NICU have been published (Diekmann et al. 2005, 
Bertino et al. 2006). If these reference charts are used to monitor the ongoing growth of 
preterm infants, extra-uterine growth retardation would be considered as normal. Hence 
they may not be ideal for monitoring the growth of preterm infants. However, these charts 
give an idea of what can be achieved with the available resources and limits set by the 
morbidities of prematurity and can be used compare the growth of preterm infants between 
different units.  
4.5 A note of caution regarding the use of intra uterine growth charts 
Intra uterine growth charts may appear idealistic goals, but one needs to decide if it is really 
feasible and safe to attain those parameters. Attempts to promote physical growth by 
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aggressive enteral and parenteral nutrition have the potential to harm the sick preterm 
infant. Rapid increase in enteral feeding is a known risk factor for NEC (Berseth et al. 2003). 
In ELBW infants, high fluid intake associated with less weight loss during the first 10 days 
of life is associated with an increased risk of death and BPD (Oh et al. 2005, Wadhawan et al. 
2007). In addition excessive catch up growth may result in adverse cardiovascular outcomes 
later in life. Finken et al(Finken et al. 2006) and Euser etal(Euser et al. 2005) found that in 
subjects born very preterm, rapid weight gain in infancy was associated with a trend 
towards higher insulin levels at 19 years. They also concluded that rapid weight gain in both 
infancy and early childhood is a risk factor for adult adiposity and obesity. Similar concerns 
have been raised by other investigators (Ekelund et al. 2006, Singhal et al. 2007). 
4.6 Growth charts to monitor preterm infants from post-conceptional age of 40 weeks 
into early childhood  
Until recently, many countries used the growth charts released by Centers for Disease 
Control and Prevention (CDC 2000) for monitoring the growth of term infants and children. 
The same charts are usually used for ongoing growth monitoring of preterm infants  
after reaching a corrected gestational age of 40 weeks. The inherent problem with such 
charts is that they represent the actual existing growth patterns instead of recommended 
standards.  
To resolve this problem inherent with ‘reference’ charts, WHO has recently released new 
‘Standard’ growth charts for term infants and children(WHO 2006). The WHO multicentre 
growth reference study (MGRS), was conducted between 1997 and 2003 in 6 countries from 
diverse geographical regions: Brazil, Ghana, India, Norway, Oman and the United States. 
The study combined a longitudinal follow-up of 882 infants from birth to 24 months with a 
cross-sectional component of 6669 children aged 18-71 months. The study populations lived 
in socioeconomic conditions favourable to growth. The individual inclusion criteria for the 
longitudinal component were: no known health or environmental constraints to growth, 
mothers willing to follow MGRS feeding recommendations (i.e. exclusive or predominant 
breastfeeding for at least 4 months, introduction of complementary foods by 6 months of age 
and continued breastfeeding to at least 12 months of age), no maternal smoking before and 
after delivery, single-term birth and absence of significant morbidity. The eligibility criteria 
for the cross-sectional component were the same as those for the longitudinal component 
with the exception of infant feeding practices. A minimum of 3 months of any breastfeeding 
was required for participants in the study's cross-sectional component. Weight-for-age, 
length/height-for-age, weight-for-length/height and body mass index-for-age percentile 
and Z-score values were generated for boys and girls aged 0-60 months. The pooled sample 
from the 6 participating countries allowed the development of a truly international 
reference. The standards explicitly identify breastfeeding as the biological norm and 
establish the breastfed child as the normative model for growth and development. They also 
demonstrate that healthy children from around the world who are raised in healthy 
environments and follow recommended feeding practices have strikingly similar patterns of 
growth. These charts are recommendations for how children should grow. More than 100 
countries including UK, USA, Canada and New Zealand have started using the WHO growth 
charts for full term infants. The full set of tables and charts are available on the WHO website 
(www.who.int/childgrowth/en) together with tools such as software and training materials.  
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In the absence of other ideal growth charts, it may be reasonable to use these WHO growth 
charts to monitor the ongoing growth of preterm infants after reaching post-conceptional 
age of 40 weeks. 
4.7 Future research 
As discussed above, neither “intrauterine growth charts”, “fetal growth charts” nor 
“postnatal growth charts” are suitable for monitoring the growth of preterm infants till they 
become term. Similarly, CDC 2000 and WHO 2006 growth charts are also not ideal for 
monitoring the growth of ex-preterm infants. 
In order to establish normative growth charts, the Inter Growth 21st study by the International 
Fetal and Newborn Growth Consortium has commenced ('http://www.intergrowth21.org.uk/' 
Accessed 18 September, 2011). The study aims to recruit 4500 healthy women aged 18-35, 
who had regular menstrual cycles and conceived spontaneously and do not have major 
health issues and practice healthy lifestyles. Study participant women are recruited from 9 
countries across five continents. They undergo 6 scans in addition to the initial dating scans. 
They are scheduled at 5 weekly intervals: 14-18 weeks, 19-23 weeks, 24-28 weeks, 29-
33weeks, 34-38 weeks and 39-42 weeks. Apart from the additional scans, they receive the 
standardized antenatal care. Based on expected 9% rate of prematurity, it is expected that 
around 360 infants would be born to these mothers (26-37 weeks gestation). Their 
longitudinal growth will be monitored for 8 months. This would include measuring weight, 
length and head circumference every 2 weeks for the first eight weeks and then monthly 
until eight months after birth. Those suffering from death or serious morbidities of 
prematurity such as NEC will be excluded. This will study will enable the derivation of 
prescriptive intrauterine growth curves as well as postnatal growth curves from a diverse 
population across five continents. 
In summary: 
1. Intra uterine growth curves, even though are not ideal, are recommended by leading 
professional paediatric organisations. In the absence of better charts, they are to be used 
for monitoring the growth of preterm infants.  
2. Postnatal growth curves describe the actual growth and hence are descriptive rather 
than prescriptive. They are not suitable for monitoring the growth of preterm infants. 
3. The aim when caring for preterm infants is to at least match the growth velocity of 
published best postnatal growth curves and strive towards reaching ideal growth 
velocities of intrauterine growth curves. 
4. Due to improvements in management of sick preterm infants, the growth of these 
infants in 1990 and 2000s is different from those of previous years. Hence it is preferable 
to use the growth curves developed based on preterm infants born after 1990. 
5. The Fenton chart which has updated the Babson and Benda’s chart with data from very 
large sample size of preterm infants born in the last two decades appears to be suitable 
for monitoring growth of preterm infants during their stay in the neonatal units.  
6. Once a post-conceptional age of 40 weeks is reached, the recently released WHO growth 
curves can be used to monitor their ongoing growth.  
7. While aiming for achieving intrauterine growth velocities in postnatal life, one should 
not lose sight of the potential short term adverse effects of aggressive nutrition and long 
term adverse effects of excessive catch up growth. 
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The currently ongoing “Intergrowth-21st study” has the potential to overcome the 
deficiencies of all the existing growth curves and will enable the establishment of 
prescriptive growth curves for monitoring the growth of preterm infants during and beyond 
their NICU stay into early childhood. 
5. Probiotics for the prevention of necrotizing enterocolitis 
Necrotizing enterocolitis is a devastating condition in preterm and very low birth weight 
neonates and carries significant mortality and morbidity (Berrington et al. 2011). Survivors 
of NEC suffer from significant adverse neurodevelopmental outcomes(Schulzke et al. 2007). 
The commonly employed strategies for its prevention are standardised feeding regimen, 
slow initiation and progression of enteral feeds and preferential use of breast milk (Morgan 
et al. 2011). In spite of these measures, NEC continues to occur and the latest figures suggest 
that the incidence in extremely low gestational age neonates is around 11%(Stoll et al. 2010).  
Gastro-intestinal colonisation by pathogenic bacteria is one of the important factors in the 
pathogenesis of necrotising enterocolitis(Claud and Walker 2001).  
Probiotics are defined as live microbial supplements that colonise the gut while providing 
benefits to the host(Millar et al. 2003). Supplementation with probiotic organisms have been 
shown to replace the pathogenic bacteria from the intestines by the normal healthy flora. 
This rationale lead to the conduct of randomised controlled trials, majority of which have 
consistently shown that probiotic supplementation reduces the incidence of severe 
necrotising enterocolitis (≥stage 2). Our meta analysis on this subject estimated a 
significantly lower risk of NEC in the probiotic group (relative risk [RR]: 0.35 [95% 
confidence interval (CI): 0.23–0.55]; P < .00001)(Deshpande et al. 2010). We concluded that 
further placebo controlled RCTs may not be necessary and probiotic supplementation 
should be offered routinely for all preterm infants. The updated Cochrane review also 
expressed similar sentiments (Alfaleh et al. 2011). However, others still are skeptical and 
advocate caution (Soll 2010, Neu and Shuster 2010) while others feel the evidence is enough 
to warrant routine use (Tarnow-Mordi et al. 2010, Barrington 2011) 
Further to this, our group has published evidence based guidelines for the administration of 
probiotics in preterm infants for those who believe in probiotic supplementation 
(Deshpande et al. 2011). Our suggestions for the routine administration of probiotics for 
preterm infants (≤ 34 weeks) are as follows: 
a. Selection of strains: Combination containing Lactobacillus and at least one 
Bifidobacterium species is preferable. Lactobacillus GG alone may not be effective. 
Dose: 3 × 109 organisms per day, preferably in a single dose 
b. When to commence: When the neonate is ready for enteral feeds, preferably within first 
7 days of life. 
c. How long to continue: At least until 35 weeks corrected age, or discharge. 
d. When to stop: Stopping the supplementation during an acute illness such as sepsis, 
NEC or perinatal asphyxia may be safe. 
A very important step is to find a good quality product meeting the strict criteria of 
individual countries’ drug administration bodies is essential. 
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6. Neonatal short bowel syndrome 
Short-bowel syndrome (SBS), which results from surgical resection or congenital defect 
(Goulet and Ruemmele 2006, O’Keefe et al. 2006) is a sub category of intestinal failure. 
Intestinal failure is defined as intrinsic bowel disease resulting in an inability to sustain 
growth, hydration and electrolyte homeostasis unless parenteral nutrition is provided. 
Intestinal failure results from intestinal obstruction, dysmotility, surgical resection, congenital 
defects, or disease-associated loss of absorption and is characterized by the inability to 
maintain protein-energy, fluid, electrolyte, or micronutrient balance. The Canadian 
Association of Pediatric Surgeons defines SBS as the need for parenteral nutrition greater than 
42 days after bowel resection or a residual small bowel length of less than 25% expected for 
gestational age (Wales et al. 2005). Normal small bowel length increases from 1145 cm between 
19 and 27 weeks of gestation through to 172 cm between 27 and 35 weeks of gestation to a 
length of 248 cm in neonates greater than 35 weeks of gestation (Touloukian and Smith 1983). 
At 1 year of age, small bowel length is approximately 380 cm (Touloukian and Smith 1983).  
The primary aetiologies of SBS in neonatal population are: Necrotizing enterocolitis, 
intestinal atresias, gastroschisis, malrotation with volvulus, and Hirschprung’s disease that 
extends into the small bowel(Gutierrez et al. 2011). 
The principles of management involve multidisciplinary approach focused on nutritional, 
pharmacologic, and surgical interventions that is directed to achieve maximal gut 
adaptation and full enteral nutrition while minimizing the complications of PN therapy.  
Providing nutrition parenterally is the essential until the gut adaptation is complete and full 
enteral feeds are tolerated to maintain growth, hydration and electrolyte homeostasis 
Adequate Glucose, amino acids, lipids and micronutrients should be administered to optimize 
growth and development. Generally it is recommended that the amount of glucose not to 
exceed 18g/kg body weight/day(Koletzko et al. 2008), which is shown to be the maximum 
rate of glucose utilisation. Excessive glucose infusion is considered to be one of the 
contributing factor for the development of intestinal failure associated liver disease (IFALD). 
Lipids are an important source of energy, essential fatty acids and fat soluble vitamins and 
an essential component of any parenteral nutrition (PN) regimen. Soya bean based lipid 
emulsions are the commonly used lipid source in most PN solutions. There is increasing 
evidence that soya bean based lipid emulsions can result in liver disease due to the pro-
inflammatory nature of the w-6 fatty acids. Fish oil based lipid emulsions are rich in w-3 
fatty acids which are anti inflammatory and have been shown to be protective against 
IFLAD and hence are preferred in patients with SBS, especially in those who are likely to 
need long term PN support(Fallon et al. 2010, Lilja et al. 2011). 
Low serum bicarbonate and sodium levels are common in patients with SBS due to 
increased fecal or stoma loss. The former may be managed by increasing acetate in the PN or 
enteral supplementation of sodium bicarbonate as tolerated. An important but often 
neglected complication is chronic body sodium depletion in babies with short gut. 
Prolonged sodium losses and inadequate supplementation leads to growth failure in 
neonates. Serum sodium levels may be maintained in the normal range despite inadequate 
supplementation due to compensatory hyperaldosteronism. Adequate sodium should be 
administered in the PN or enterally to maintain urinary sodium of > 30meq/l and 
sodium/potassium ratio of atleast 1 (Kocoshis 2010). 
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It is important to commence enteral feeds as soon as feasible to prevent complications of 
TPN and to enable intestinal growth and adaptation. A recent systematic review found very 
limited number high quality studies addressing the issue of enteral nutrition in infants and 
children with SBS (Olieman et al. 2010). Hence most of the recommendations are expert 
opinions or consensus based:  
a. Enteral nutrition should be initiated as soon as possible (ie, a few days after bowel 
resection). Volumes should be gradually increased by 1 mL/hr twice a week. Tolerance 
of new volumes can be assessed by (a) vomiting (more than three times per day/more 
than 20% of their daily enteral intake is extensive and indicates intolerance) and (b) 
quantity and consistency of stool, pH, and sugar reduction of stool. Enteral feeds could 
be advanced as long as stool or stomal output is <2 mL/kg/h. Because not all enterally 
administered calories will be absorbed, PN should not be decreased iso-calorically, 
especially in the initial stages. 
b.  Continuous enteral nutrition is the recommended mode of administration as it tends to 
cause less diarrhoea in patients with SBS. 
c. The use of breast milk is recommended. The use of breast milk (BM) has been shown to 
correlate with shorter PN courses and to promote intestinal adaptation. Beneficial 
components of BM include high levels of nucleotides, amino acids, and immunologic 
and growth factors. BM also has anti-infectious properties, and glycoproteins in BM 
deliver iron to the intestinal epithelium, stimulate proliferation and differentiation of 
crypt cells, influence brush border enzyme activity, and function as scavengers to 
prevent free radical–mediated tissue damage.  
d. Amino acid–based formulas have been associated with a shorter duration of PN-
dependence when compared with standard formula and can be used if BM is not 
tolerated.  
e. It is recommended to start oral-feeding as soon as possible. Oral feeding can be 
alternated with continuous enteral feeding. For example, continuous feeding might be 
stopped for 1 hour, and replaced by a 1-hour dose per bottle or short times of breast 
feeding. Solid food should be introduced at the age of 4 to 6 months, in low volumes to 
prevent diarrhea. 
f. Animal studies have shown that administration of colostrums protein concentrate may 
enhance the intestinal adaptation after massive bowel resection (Nagy et al. 2004).  
Neonates with SBS may have significant stool or stomal output that precludes transition to 
enteral feeds. Analysis of stool or stomal effluent for specific carbohydrate malabsorption 
(stool reducing substances and chromatography) and microscopy for fat globules will give 
valuable clues which will help modification of enteral formula in a rational manner. If no 
mechanical or infectious issues are evident, loperamide may be used to decrease stool or 
stomal output. Stomal re-feeding is also an effective strategy in patients with a long mucous 
fistula. Early stoma closure should be considered if significant fluid electrolyte imbalance 
occur due to high stomal loss and good length of colon is remaining.  
6.1 Predictors of outcome in neonates with SBS 
Eventual independence from PN support in short gut depends on various factors, including 
the residual length of neonatal small bowel, the health and adaptability of the remaining 
small bowel, presence of ileocaecal valve (ICV) and of colon. Traditionally a small bowel 
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length of 15 cm in the presence of ICV and 40 cm in the absence of ICV have been described 
as minimum essential for survival in patients with short bowel syndrome. 35 cm of neonatal 
small bowel is associated with a 50% probability of weaning from PN (Andorsky et al. 2001).  
Recent data suggests that percentage of expected small bowel for age rather than the 
absolute length may be a better predictor of outcomes (Wales and Christison-Lagay 2010, 
Diamond et al. 2010). In general, it is accepted that ileum is more adaptable than jejunum. A 
dilated, dysmotile gut fairs poorly than a healthy residual gut. The importance of viable 
colon in the survival of neonates and children with SBS is not clear with some studies 
showing benefit (Quiros-Tejeira et al. 2004) while the others did not (Diamond et al. 2010). 
The presence of colon is helpful because in patients with SBS, when undigested nutrients 
reach the colon it may induce changes that allow the colonic mucosa to enhance its capacity 
of water and electrolyte absorption as well as modifications that allow absorption of 
nutrients such as short- and medium-chain fatty acids. As more intact nutrients reach the 
colon, trophic hormones such as enteroglucagon may be stimulated, contributing to the 
intestinal adaptation process. Premature neonates may be at a distinct advantage with 
regard to intestinal adaptation (Goday 2009).  
The ICV slows the transit time of intestinal contents and prevents reflux of colonic contents 
and bacteria into the ileum. Resection of the ICV can cause bacterial reflux into the small 
bowel. The ensuing bacterial overgrowth can deconjugate bile salts, reduce bile salt 
absorption, and impair gut function. Most studies have identified preservation of the ICV as 
a favourable indicator of long term adaptation although recent studies have not found the 
presence of intact ICV to be predictor of final outcomes (Diamond et al. 2010, Spencer et al. 
2005). Citrulline is a non-structural amino acid that is primarily synthesized in the intestinal 
mucosa and hence reflects mucosal mass. Serum Citrulline levels correlate well with 
intestinal length and the ability to wean from PN. Infants with serum citrulline level 
persistently <15 mmol/L are usually unable to wean from PN (Fitzgibbons et al. 2009). The 
surgical treatment options for neonatal SBS in some centres include bowel conservation at 
the time of initial presentation, bowel lengthening operations and intestinal transplantation. 
However, recent experience suggests that the outcomes for infants and children with severe 
intestinal failure have improved over time and that neonates with extremely short gut, even 
as low as 10-20 cm of small intestine, eventually are able to be weaned off from the 
parenteral nutrition(Sala et al. 2010, Khalil et al. 2011). 
6.2 Complications of SBS 
Three specific complications are frequently associated with SBS: Intestinal Failure Associated 
Liver Disease (IFALD), Catheter Associated Blood Stream Infections (CABSI) and bacterial 
overgrowth. In addition poor growth and development will occur if adequate calories, 
electrolytes and micronutrients are not provided via PN. 
IFALD is a common and potentially life-threatening problem for paediatric patients 
receiving long-term parenteral nutrition (PN). The incidence increases with the duration of 
TPN(Buchman 2002) and can be as high as 85% in neonates receiving TPN for prolonged 
periods of time. The clinical spectrum of IFALD includes hepatic steatosis, cholestasis, 
fibrosis, and, ultimately, progression to hepatic cirrhosis with portal hypertension and end-
stage liver disease. Though the cause of IFALD is multifactorial, the single most important 
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factor responsible is lack of enteral feeds. Other contributing factors include prematurity, 
reduced bile acid pool, CABSIs, chronic endotoxemia, toxic constituents in PN, excess 
glucose and fat in PN. Lipid emulsions derived from soybean oils have been shown to cause 
liver injury both in vitro and in vivo in rodent models. Preventative strategies include 
enteral feeding, weaning of PN, reduced dose lipid emulsions and the early recognition and 
treatment of sepsis. Recent studies have demonstrated the efficacy of fish-oil based lipid 
emulsions in the prevention and treatment of IFALD (Lilja et al. 2011, Fallon et al. 2010) and 
has to be incorporated in routine clinical practice. Transplantation is an option for end-stage 
liver disease but is associated with significant morbidity and mortality(Nehra et al. 2011). 
A systematic review of observational studies concluded that Ursodeoxycholic acid may lead 
to short-term improvement in biochemical indices, but sample size was very small and the 
risk of bias very high(San Luis and Btaiche 2007). Based on the limited evidence available, 
ursodeoxycholic acid (10 mg/kg/dose twice or 3 times daily) may be tried in infants with 
IFALD who are able to tolerate some enteral intake.  
CABSI can result in the loss of the central venous line, recurrent admissions to the hospital 
and worsen the existing liver injury. Diagnosis includes blood cultures collected from the 
central line. Treatment includes administration of antibiotic through the central line. In case 
of fulminant or resistant infection, the catheter will need to be removed. Preventative 
strategies include following strict protocols and aseptic precautions during insertion and 
management of the CVCs. A promising therapy in the prevention of CABSI is the use of 
ethanol locks(Wales et al. 2011). Ethanol has been demonstrated to have the ability to 
penetrate biofilms that form on central lines, and no bacteria or fungi have been reported to 
be resistant to ethanol. A recent retrospective study showed a fourfold reduction in CABSI 
in the cohort-administered ethanol locks (Jones et al. 2010). 
Areas of disordered motility and bowel dilation in patients with SBS offer an ideal 
environment for abnormal bacterial propagation. The adverse effects of bacterial 
overgrowth include: abdominal pain, worsening motility, mucosal ulceration with bleeding, 
deconjugation of bile acids, and the generation of toxic byproducts such as D-lactic acid. 
Bacterial overgrowth can also potentiate translocation and cause septicemia. The treatment 
for suspected bacterial overgrowth is the administration of enteral antibiotics in a cyclical 
fashion. Antibiotics that are commonly used include those effective against anaerobes or 
Gram-negative organisms(Gutierrez et al. 2011). Systemically non absorbable antibiotics are 
preferred. 
7. Malrotation and volvulus of the intestines in neonates 
Malrotation is a serious congenital condition wherein the normal process of embryonic gut 
rotation is arrested or altered. The abnormal rotation usually involves both small and large 
bowel, within the peritoneal cavity. The most important feature is that the abnormally 
rotated bowel does not have a normal mesenteric attachment. The mesenteric attachment is 
frequently short and prone to volvulus when part of the intestine loops around the 
mesentery and intestines resulting in bowel obstruction and gangrene secondary to 
occlusion of the branches of the mesenteric artery (Figure 1a and 1b). Volvulus renders the 
entire bowel at risk of ischemia and necrosis. The intestinal obstruction with congenital 
malrotation can also result from the congenital fibrous bands (Figure 2a and 2b).  
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Fig. 1. a. Normal: the mesenteric root is broad, extending from the duodenojejunal junction 
in the left upper quadrant to the caecum in the right lower quadrant. b. Malrotation: the 
mesenteric root is narrow, predisposing to volvulus. 
 
 
Fig. 2. Ladd’s bands extend from the caecum (a) or ascending colon (b) to the right upper 
quadrant, passing across and variably obstructing the duodenum. 
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Clinical features depend on the nature and degree of obstruction (which may be 
intermittent) and the presence or absence of vascular compromise. Presentation can be 
asymptomatic but usually results in vomiting often bilious and or abdominal distension. 60–
80% of patients with malrotation present in the first month of life, mostly in the first week. 
Bilious vomiting is an important sign of malrotation and must be promptly investigated 
(William 2007, Kumar 2003)). Even in the absence of bilious vomiting, malrotation/volvulus 
should be suspected in any neonate presenting with distended abdomen. Even though bilious 
aspirates can be a sign of dysmotility in extremely premature infants, persistently prolonged 
bilious aspirates especially lasting more than a week should raise the suspicion of malrotation. 
Presence of chylous fluid in the inguinal hernia sac during inguinal hernia repair should 
also alert the surgeons to the possibility of associated malrotation (Zarrouq 2010).  
The best imaging test for the diagnosis of malrotation is an upper GI contrast study which 
will show an abnormal duodenum and duodeno-jejunal (DJ) flexure position (Applegate 
2009). It is an emergency investigation and should not be deferred. The normal position of 
the DJ flexure is to the left of the spine and at the same level or higher than the duodenal 
bulb. In malrotation, there is no normal duodenal configuration and the proximal small 
bowel is in the right side of the abdomen (figure 3a and 3b). 
Ultrasound and contrast enema may provide additional information but are not sufficiently 
accurate to exclude malrotation (Danse 2007, Chao 2000). Presence of normal lactate levels, 
blood pressure, urine output, blood gases do not rule out the diagnosis of intestinal 
gangrene secondary to malrotation/volvulus. Once a diagnosis of malrotation and or 
volvulus is confirmed, urgent surgical review with a view to laparotomy is indicated. Delay 
in the diagnosis or laparotomy may lead to ischemic necrosis of the bowel. 
 
Fig. 3. a. Normal upper gastrointestinal contrast study (AP view) in a neonate with bilious 
vomiting. Contrast medium was introduced via a nasogastric tube. The duodeno-jejunal 
flexure is arrowed  
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Fig. 3. b. Malrotation. There is no normal duodenal configuration and the proximal small 
bowel is in the right side of the abdomen. 
Treatment is with the standard Ladd’s procedure which involves untwisting of the volvulus, 
division of the Ladd’s bands, broadening of the narrow base of the mesentery, division of 
the adhesions along the small bowel and returning the bowel in a non rotated position. 
Small bowel is positioned in the right abdomen and the colon in the left abdomen and 
appendicectomy performed (Millar 2003). 
In summary, high index of suspicion, prompt investigation and early laparotomy are 
essential for the prevention of serious gut related morbidity and mortality secondary to 
malrotation and volvulus. 
8. Gastroschisis 
Gastroschisis is a congenital defect of the abdominal wall usually located to the right of the 
umbilical cord, through which abdominal organs herniate. It should be distinguished from 
omphalocele (or exomphalos), which results from failure of normal return of the bowel to 
the abdominal cavity during early fetal life. Result in herniated bowel with peritoneal 
covering and the umbilical cord inserted into the apex of the hernia. Distinguishing these 
two conditions is very important because they carry different prognoses and the temptation 
to combine these diseases together as ‘anterior abdominal wall defects’ should be avoided. 
Gastroschisis occurs in up to 5 in every 10 000 live births with a sex ratio of approximately 1. 
Recent epidemiological surveillance data have shown a 10-20-fold increase in the overall 
 
Recent Advances in Neonatal Gastroenterology and Neonatal Nutrition 
 
57 
incidence of gastroschisis in all age groups over the past two decades (Rasmussen and Frias 
2008, Loane et al. 2011, Frolov et al. 2010, Clark et al. 2009). 
Pathogenesis of gastroschisis is unknown, but various factors are associated with an 
increased risk of gastroschisis. They include young maternal age, first pregnancy, low 
socioeconomic status, lower pre-pregnancy body mass index (BMI), poor maternal diet, 
disordered family life, use of medications such as aspirin, Ibuprofen, nasal decongestants, 
maternal infection, smoking, alcohol cocaine, marijuana and genetic polymorphisms (Jones 
et al. 2009, Mac Bird et al. 2009, Rasmussen and Frias 2008). 
More than 90% patients are diagnosed antenatally using ultrasound (Baird et al. 2011, Garne 
et al. 2010). The typical sonographic feature is multiple loops of bowel floating freely in the 
amniotic fluid after the time of normal embryonic return of the intestines to the abdominal 
cavity (10 weeks of gestation). Typically, the herniated bowel is seen to the right of the 
umbilical cord insertion, which is inserted normally into the anterior abdominal wall to the 
left of the herniated bowel. Excluding exomphalos is important in prenatal diagnosis, since 
exampholos is associated with aneuploidy in up to 40% of patients, and/or structural 
abnormalities of other organs. 
Ultrasonographic assessment at regular intervals, usually every 2 weeks, is recommended 
after the diagnosis, to monitor foetal growth and bowel status. Development of 
polyhydromnios(Japaraj et al. 2003) or of progressive bowel dilatation is considered by some 
to indicate a poor prognosis (David et al. 2008, Payne et al. 2009) and may warrant early 
delivery. 
Mode of delivery appears not to influence the survival or short term outcomes of 
gastroschisis and hence caesarean section per se for gastroschisis may not be necessary 
(Abdel-Latif et al. 2008). Timing of delivery is controversial with some advocating delivery 
before 37 weeks (Hadidi et al. 2008, Moir et al. 2004, Reigstad et al. 2011). However, since 
prematurity and low birth weight are associated with increased morbidities in neonates 
with gastroschisis, many advocate delivery at term in the absence of other obstetric 
complications or fetal compromise (Ergun et al. 2005, Maramreddy et al. 2009, Logghe et al. 
2005). 
Following delivery, adequate intravenous fluid resuscitation must be administered as there 
will be significant evaporative water losses from the exposed bowel. It is important to 
prevent intestinal distension by gastric decompression with a large bore nasogastric tube. 
The herniated bowel should be enclosed in a sterile plastic bag or wrapped in warm saline-
soaked gauze with plastic wrap. The baby should be positioned on the right side to prevent 
kinking of the mesentery. The bowel needs be examined for evidence of intestinal atresia, 
necrosis or perforation. 
Various surgical methods have been used to achieve the goal of safe reduction of the 
herniated viscera back into the abdominal cavity at the earliest possible time (Holland et al. 
2010). Options include: (i) Complete primary reduction under general anaesthesia (ii) 
Complete primary reduction without the use of general anaesthesia (ward reduction) and 
(iii) application of preformed spring loaded silo followed by gradual reductions over few days. 
Primary reduction under general anaesthesia is the traditional and commonly used 
approach is to reduce the viscera followed by the closure of the fascia and the skin with 
 
Neonatal Care 
 
58
sutures under general anaesthesia (Owen et al. 2010). It will also enable the repair of 
associated anomalies such as intestinal atresia. Any significant rise in the ventilator 
requirements during or immediately after the surgical procedure would alert the surgeons 
to the possibility of abdominal compartment syndrome. In such situations, usually a silo is 
applied and the viscera gradually reduced over the next few days.  
Primary reduction in the ward without the use of general anaesthesia practised this approach 
with reasonable success (Bianchi et al. 2002, Davies et al. 2005, Cauchi et al. 2006) , whereas the 
others have found increased complications secondary to abdominal compartment syndrome 
(Rao et al. 2009, Dolgin et al. 2000). The idea behind this approach is the potential for 
avoidance of general anaesthesia, avoidance of transfer to a surgical unit and facilitation of 
early enteral feeds because complete reduction has been achieved very early. This approach 
was pioneered in the United Kingdom, (Bianchi et al. 2002) but not adopted with 
enthusiasm (Owen et al. 2010). In Western Australia, this procedure has been abandoned in 
view of high incidence of complications(Rao et al. 2009). 
Staged reduction using Silos is the preferred approach in Western Australia. Preformed 
spring loaded silos can be placed into the abdominal defect at the bedside to hold the 
herniated contents. This usually does not require general anaesthesia. Subsequently, the 
bowel is reduced once or twice daily into the abdominal cavity as the silo is shortened by 
sequential ligation. This process usually takes between one and 14 days, depending on the 
condition of the bowel and the infant. Definitive closure is performed once the complete 
reduction has been achieved. Advantages of this method are the avoidance of iatrogenic 
intestinal ischemia secondary to abdominal compartment syndrome. Staged reduction using 
preformed Silos has been found to be safe and effective in many observational studies 
(Owen et al. 2006, Allotey et al. 2007) and an RCT (Pastor et al. 2008) . 
In situations where closure of the abdominal wall defect cannot be achieved with sutures, 
options are: Using umbilicus as an allograft; Prosthetic materials such as non-absorbable 
mesh; and biosynthetic absorbable patches such as dura or porcine small intestinal sub 
mucosa.  
Postoperatively, it is important to watch for evidence of abdominal compartment syndrome 
because of the risk of iatrogenic ischemic necrosis of the bowel. Clinical features are low 
urine output, poor perfusion, high ventilatory requirements, need for high doses of narcotic 
analgesia (ischemic gut), metabolic acidosis and elevated lactate levels. Regular clinical 
review is extremely important and there should be low threshold for re-laparotomy. Some 
units use intra-gastric or urinary bladder (intra-vesical) pressures as indirect measures of 
intra-abdominal pressure. Values more than 20 mm Hg are thought to indicate the 
occurrence of this problem (Lacey et al. 1987). 
A nasogastric tube should be utilized for gastric decompression in the post operative period. 
Feeding can commence as early as 2-3 days post operatively once haemodynamic and 
respiratory stability has been achieved. Early commencement of feeding can facilitate 
attainment of full enteral feeds soon (Sharp et al. 2000). 
Gastroschisis is associated with abnormal intestinal motility and nutrient absorption, both of 
which gradually improve over time in most patients. Growth should be maintained with 
appropriate parenteral nutrition. Some infants develop short gut syndrome due to either 
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functional dysmotility or anatomically short length of small intestines. Fish oil based lipid 
emulsions may be beneficial in reducing the severity or prevention of TPN associated 
cholestasis in such infants (Deshpande and Simmer 2011). Prokinetics such as Erythromycin 
have not been found to be useful for feed intolerance associated with gastroschisis (Curry et 
al. 2004). 
Survival rate of neonates with gastroschisis is high (93-97%) (Abdel-Latif et al. 2008, Baird et 
al. 2011, Minutillo C 2009, Owen et al. 2010). The median time to discharge home range 
between 23 to 47 days (Minutillo C 2009, Baird et al. 2011), infants with short gut syndrome 
have very prolonged hospitalisation with the risk of complications of prolonged TPN 
therapy such as cholestasis and recurrent infections. Limited information available on the 
physical growth and neurodevelopmental outcomes suggests that treated infants have a 
good long term prognosis (Minutillo C 2009, Henrich et al. 2008). 
In summary, the incidence of Gastroschisis has increased markedly over the past two 
decades. The majority of infants are diagnosed with early trimester ultrasonography. 
Primary reduction under general anaesthesia or gradual reduction using preformed silos is 
preferable and commonly used mode of reducing the contents into the abdominal cavity. A 
small percentage of cases develop short gut syndrome and need TPN for a protracted length 
of time. Survival of live born neonates with gastroschisis is very high (>93%) and limited 
data suggest that long term outcomes are good.  
9. Neonatal hemochromatosis  
Neonatal hemochromatosis(NH) is defined as severe neonatal liver disease in association 
with extra-hepatic iron accumulation(Whitington 2007). It is a serious disease and usually 
leads to death either in utero or in the early neonatal period (mortality rates 70-80%). It is the 
single most common cause of neonatal liver failure(Shanmugam et al. 2011).  
The onset of the disease is in utero. Currently it is hypothesised to be an alloimmune process 
with maternal sensitization to a fetal liver antigen leading to immune injury of the fetal liver 
and subsequent mishandling and deposition of iron in the liver and extra hepatic 
tissues(Whitington 2007). Iron deposition (Siderosis) occurs in the liver and extra-hepatic 
tissues such as pancreas, heart, thyroid and salivary glands. Siderosis explicitly spares the 
reticulo-endothelial cells(Murray and Kowdley 2001).  
The genetics of NH is unknown but it is not linked to the adult haemochromatosis. NH has 
a recurrence risk of approximately 80% within sibships of same mother but not the father, 
suggesting the role of a maternal alloimmune factor (Knisely et al. 2003). There are also 
recent reports of mitochondrial depletion syndromes presenting as NH(Hanchard et al. 
2011). 
Infants with NH frequently are preterm or small for gestational age. Pregnancy may be 
complicated by intrauterine growth retardation, oligohydramnios, placental edema, or 
polyhydromnios. Affected neonates develop features of liver failure with hypoalbuminemia, 
hypoglycemia, coagulopathy, low fibrinogen, thrombocytopenia and anaemia. If not present 
at birth, ascites and hyperbilirubinemia develop within a few days to weeks. Transaminase 
levels are generally either normal or only moderately elevated suggesting severe intrauterine 
hepatic damage. 
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NH should be suspected in any sick newborn with evidence of liver disease and in cases of 
late intrauterine fetal demise.  
No single biochemical test is diagnostic of NH. Diagnosis is made after ruling out other 
causes of liver cell failure in neonates (Murray and Kowdley 2001). This includes various 
infectious, metabolic, storage and other disorders. In NH, Serum Ferritin levels and 
Transferrin saturations are raised commonly 95-100%. However, ferritin is an acute phase 
reactant and elevated levels are seen in many other conditions causing neonatal liver failure 
and hence, non-diagnostic. The hall mark of NH is extrahepatic siderosis with sparing of 
reticuloendothelial system. Therefore, in the face of severe coagulopathy, Salivary gland 
biopsy from the lips or cheek is a safe alternative to liver biopsy and effective way to 
diagnose NH(Smith et al. 2004). The histopathology of the salivary glands shows excessive 
iron deposition. Other conditions such as echovirus, CMV,HSV, neonatal lupus, 
tyrosinemia, mitochondrial diseases, rubella, parvovirus and zellweger syndrome may also 
cause excessive siderosis in extra hepatic organs including salivary glands and hence need 
to be ruled out by relevant investigations(Murray and Kowdley 2001). 
On T2-weighted sequences in MRI scans, tissues with increased iron content have low signal 
intensity. In NH, the reticulo-endothelial system is spared so that the spleen retains a 
normal, higher signal intensity compared with affected tissues such as liver, heart and 
pancreas. Comparing the signal intensity of pancreas, heart and thyroid gland to spleen can 
be helpful in the diagnosis of NH (Williams et al. 2006, Tsai et al. 2009).  
The differential diagnosis of neonatal liver failure include infections, perinatal asphyxia, 
metabolic conditions like tyrosinemia, galactosemia, Heriditary fructose intolerance, and 
urea cycle defects, Haemophagocytic Lymphohistiocytosis (HLH), mitochondrial disorders 
and Congenital disorder of glycosylation.  
Supportive management involves administration of Fresh Frozen plasma, cryoprecipitate 
and vitamin K to normalise the coagulation abnormalities. Repeated administrations for 
prolonged periods are to be expected in view of ongoing liver failure.  
Cocktail of antioxidants including selenium (3 microgram/kg/day orally), N acetyl-Cysteine 
(50-100 mg/kg/day, intravenously or orally), prostaglandin E1(0.4 microgram/kg/h, 
intravenously, for a maximum of two weeks), Desferoxamine 30 mg/kg/day, intravenously 
until the ferritin level falls to 500 ng/mL) and Vitamin E (25 IU/kg/day, orally) have been 
advocated (Grabhorn et al. 2006), but the results are disappointing (Heffron et al. 2007). Similar 
to Rand et al (2009), our suggestion is to give oral antioxidants such as vitamin E and 
Acetylcysteine and avoid intravenous antioxidants and chelating agents. Liver 
transplantation is the definitive therapy, but carries a high level of morbidity and mortality 
(Sundaram et al. 2003).  
Recent reports have suggested the beneficial role for the treatment of NH. Double volume 
exchange transfusion followed by 1-3 doses of intravenous immunoglobulin (1gram/kg) has 
been shown to significantly improve survival without the need for liver transplantations 
(Rand et al. 2009). Few authors have reported beneficial outcomes with exchange transfusion 
alone (Timpani et al. 2007, Nicastro and Iorio 2010, Escolano-Margarit et al. 2010).  
NH is the result of severe fetal liver injury that seems to result from maternal-fetal 
alloimmunity. Women who have had an infant affected with NH have approximately 80% 
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probability of recurrence in subsequent pregnancies. Recent studies have shown that weekly 
administration of IVIG to such pregnant mothers from 18 weeks of gestation till full term 
results in decreased severity of the disease and improved survival in their offsprings 
(Whitington and Kelly 2008, Nicholl 2010). 
In summary, NH is a lethal condition and until recently, there was no effective medical 
therapy. Salivary gland biopsy and MRI of the abdomen are useful investigations in the 
diagnosis of NH. Recent studies have suggested that NH is possibly alloimmune disorder. 
Treatment with IVIG during pregnancy for women who had previous child with NH can 
prevent the occurrence and severity of NH. Exchange transfusion and IVIG may improve 
survival without the need for liver transplantation for neonates diagnosed with NH. 
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